Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence
May 2, 2022
1 min read
Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing rhabdomyosarcoma recurrence. They found that these cells mirror an early developmental state that responds to EGFR inhibitors. The work presents a strategy for targeting the whole tumor that may apply to other pediatric cancers.